Table 2.
Predictors for the Receipt of Nicotine Replacement Therapy
| Predictor | OR (95% CI) |
|---|---|
| Age, y | |
| 65+ | Referent |
| 45-64 | 1.65 (1.58-1.73) |
| 18-44 | 1.57 (1.48-1.67) |
| Sex | |
| Female | Referent |
| Male | 1.01 (0.98-1.04) |
| Race | |
| White | Referent |
| Other | 0.71 (0.66-0.76) |
| Hispanic | 0.57 (0.52-0.62) |
| Black | 0.54 (0.51-0.57) |
| Insurance | |
| Medicare | Referent |
| Medicaid | 1.13 (1.08-1.19) |
| Uninsured | 1.12 (1.05-1.20) |
| Private | 0.78 (0.75-0.82) |
| Admission type | |
| Emergency | Referent |
| Elective | 0.78 (0.76-0.81) |
| Surgery classification | |
| Orthopedic | Referent |
| Plastic | 1.13 (1.05-1.21) |
| Thoracic | 1.12 (1.05-1.19) |
| Endocrine | 1.04 (0.85-1.24) |
| Vascular | 0.99 (0.92-1.05) |
| Neurologic | 0.95 (0.88-1.01) |
| Urologic | 0.88 (0.80-0.96) |
| Spinal | 0.80 (0.75-0.85) |
| GI | 0.78 (0.75-0.81) |
| Gynecologic | 0.59 (0.54-0.64) |
| Obstetric | 0.35 (0.32-0.39) |
| Comorbidities | |
| Alcohol abuse | 1.73 (1.65-1.81) |
| Chronic pulmonary disease | 1.52 (1.47-1.57) |
| Drug abuse | 1.41 (1.35-1.48) |
| Psychoses/depression | 1.29 (1.25-1.34) |
| Fluid and electrolyte disorders | 1.13 (1.08-1.17) |
| Perivascular | 1.07 (1.01-1.12) |
| Weight loss | 1.07 (1.00-1.14) |
| Paralysis/other neurologic disorders | 1.04 (0.99-1.10) |
| Hypertension | 1.03 (1.00-1.07) |
| Liver disease | 1.01 (0.94-1.08) |
| Diabetes | 0.96 (0.93-1.00) |
| Chronic blood loss anemia/deficiency anemias | 0.92 (0.88-0.96) |
| Congestive heart failure | 0.91 (0.84-0.97) |
| Hypothyroidism | 0.90 (0.85-0.94) |
| Obesity | 0.80 (0.76-0.83) |
| Renal failure | 0.76 (0.71-0.81) |
| Organ failure present on admission | |
| Hematologic | 1.09 (0.98-1.20) |
| Renal | 1.00 (0.93-1.07) |
| Cardiovascular shock | 0.99 (0.90-1.08) |
| Hepatic | 0.97 (0.78-1.16) |
| Acidosis | 0.94 (0.85-1.04) |
| Respiratory | 0.88 (0.78-0.98) |
| Neurologic | 0.81 (0.71-0.90) |